切换至 "中华医学电子期刊资源库"

中华诊断学电子杂志 ›› 2016, Vol. 04 ›› Issue (03) : 160 -163. doi: 10.3877/cma.j.issn.2095-655X.2016.03.005

所属专题: 文献

消化系统疾病与心身医学观

siRNA沉默细胞周期相关激酶基因对鼠结肠癌生长及其细胞凋亡的影响
孔令斌1, 贺军2, 张秋生2, 何恒2, 马翠梅2, 杜宗梅2, 庞道华3,()   
  1. 1. 272067 济宁医学院临床学院
    2. 272069 济宁医学院附属医院消化内科
    3. 济宁医学院公共卫生学院
  • 收稿日期:2016-02-29 出版日期:2016-08-26
  • 通信作者: 庞道华
  • 基金资助:
    山东省医药卫生科技发展计划(2013WS0335)

Effects of small interfering RNA silencing CCRK gene on the growth and apoptosis of colorectal carcinoma in nude mice

Lingbin Kong1, Jun He2, Qiusheng Zhang2, Heng He2, Cuimei Ma2, Zongmei Du2, Daohua Pang3,()   

  1. 1. Clinical College, 3Public Health College, Jining Medical University, Jining 272067, China
    2. Department of Gastroenterology, Affiliated Hospital of Jining Medical University, Jining 272069, China
  • Received:2016-02-29 Published:2016-08-26
  • Corresponding author: Daohua Pang
  • About author:
    Corresponding author: Pang Daohua, Email:
引用本文:

孔令斌, 贺军, 张秋生, 何恒, 马翠梅, 杜宗梅, 庞道华. siRNA沉默细胞周期相关激酶基因对鼠结肠癌生长及其细胞凋亡的影响[J]. 中华诊断学电子杂志, 2016, 04(03): 160-163.

Lingbin Kong, Jun He, Qiusheng Zhang, Heng He, Cuimei Ma, Zongmei Du, Daohua Pang. Effects of small interfering RNA silencing CCRK gene on the growth and apoptosis of colorectal carcinoma in nude mice[J]. Chinese Journal of Diagnostics(Electronic Edition), 2016, 04(03): 160-163.

目的

探讨siRNA沉默细胞周期相关激酶(CCRK)基因对鼠结肠癌生长及其凋亡的影响。

方法

将50只BALB/C(nu/nu)裸鼠皮下接种人类结肠癌SW480细胞,将其中建立移植瘤裸鼠模型成功的30只裸小鼠按照单纯随机抽样方法随机分为3组,分别接种siRNACCRK转染的人类结肠癌SW480细胞株(实验组)、正常培养的SW480细胞(空白对照组)和以转染携带无关序列片段sh RNA慢病毒的SW480细胞(阴性对照组)。第42天处死裸鼠后取下肿瘤组织,比较各组肿瘤重量、CCRKmRNA表达量、CCRK蛋白表达和细胞凋亡的变化。

结果

转染siRNA组肿瘤重量、CCRK mRNA和CCRK蛋白表达[(0.54±0.15)g,1.14±0.24和0.18±0.05]表达显著低于空白对照组[(1.05 ± 0.14)g,2.41±0.42和0.49±0.07]和空siRNA载体组[(1.07 ±0 .12)g,2.39±0.47,0.47±0.09;F=21.18,23.47,90.03;P<0.01];空白对照组与空siRNA载体组比较差异无统计学意义(q=0.98,1.07,1.13;P>0.05)。实验组沉默CCRK基因后组织中细胞凋亡率为(21.23±1.12)%,明显高于空白对照组(6.78±0.37)%和阴性对照组(7.25±0.32)%,差异有统计学意义(F=56.936,P<0.01);但空白对照组和空siRNA载体组之间差异无统计学意义(q=1.78,P>0.05)。

结论

CCRK靶向siRNA表达载体接种结肠癌裸鼠后能显著降低结肠癌瘤体的增长,抑制CCRK基因和蛋白表达;siRNA沉默CCRK基因能促进其凋亡,CCRK基因有望成为结直肠癌治疗的新靶点。

Objective

To investigate the effect of siRNA silencing cell cycle-related kinase (CCRK) gene on the growth and apoptosis of colon cancer in mice, and to provide a new idea and method for the treatment of colon cancer.

Methods

Fifty BALB / C (nu / nu) nude mice were inoculated with human colorectal carcinoma SW480 cells, in which 30 nude mice were successfully established for transplantation tumor model and were randomly divided into three groups, siRNA CCRK transfection of human SW480 colon cancer cell line (experimental group) and normal cultured SW480 cells (blank control group), and carrying irrelevant sequence fragment shRNA slow transfection of virus SW480 cells (negative control group) respectively.The nude mice were sacrificed and the tumor tissues were removed after 42 days.The tumor weight, CCRKmRNA expression, CCRK protein expression and apoptosis rate were compared between the groups.

Results

siRNA transfection group, tumor weight, CCRK mRNA and CCRK protein expression [(0.54±0.15)g, 1.14±0.24, 0.18±0.05] were significantly lower than those of the control group [(1.05±0.14)g, 2.41±0.42, 0.49±0.07] and empty vector of siRNA group [(1.07±0.12)g, 2.39±0.47, 0.47±0.09, F=21.18, 23.47, 90.03; P<0.01]. There were no significant differences between the blank control group and the empty siRNA vector group (q=0.98, 1.07, 1.13; P>0.05). Cells apoptosis rate in siRNA transfection group (21.23±1.12)% was significantly higher than that in normal control group (6.78±0.37)% and transfected with empty vector of siRNA group (7.25±0.32)% (P<0.01); but there was no significant difference between the blank control group and the empty siRNA vector group (q=1.78, P>0.05).

Conclusions

CCRK targeting siRNA expression vector inoculation with colon cancer can significantly reduce the growth of colon cancer and inhibit the expression of CCRK gene and protein in nude mice; CCRK gene silencing by siRNA can promote the colon cancer cells apoptosis; thus , CCRK gene can serve as a new potential molecular target for rectal cancer in gene therapy by siRNA.

图1 免疫组化法检测不同组别瘤组织CCRK蛋白表达(HE ×400)。示转染siRNA组(a)CCRK mRNA和CCRK蛋白表达明显低于空白对照组(b)和阴性对照组(c)(箭头所示);CCRK为细胞周期相关激酶
[1]
Siegel R,Ma J,Zou Z, et al.Cancer statistics, 2014[J]. CA Cancer J Clin, 2014, 64(1): 9-29.
[2]
李凯,赵卫星,鲍永华, 等. 胃炎、食管炎和食管癌患者血清中人丝氨酸蛋白酶8的表达及临床意义[J/CD]. 中华诊断学电子杂志, 2016, 4(1): 45-47.
[3]
Cicenas J,Valius M. The CDK inhibitors in cancer research and therapy[J]. Cancer Res Clin Oncol, 2011, 137(10): 1409-1418.
[4]
王茜,杨景玉,曲锦, 等. 细胞周期相关激酶在大肠癌组织中的表达及其意义[J]. 中国病原微生物学杂志, 2015, 10(3): 228-231.
[5]
Guo S,Kemphues KJ.Par-1α gene required for establishing polarity in celegant embryos, encodes a putative Ser/Thr kinase that is asymmetrically distributed[J]. Cell, 1995, 81(4): 611-620.
[6]
Caplen NJ,Parrish S,Imani F, et al. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems[J]. Proc natl Acad Sci USA, 2001, 98(17): 9742-9747.
[7]
Hammond SM,Caudy AA,Hannon GJ. Post-transcriptional gene silencing by double-stranded RNA[J]. Nat Rev Genet, 2001, 2(2): 110-119.
[8]
Novina CD,Murray MF,Dykxhoorn DM, et al. siRNA-directed inhibition of HIV-l infection[J]. Nat Med, 2002, 8(7): 681-686.
[9]
Kryštof V,Uldrijan S. Cyclin-dependent kinase inhibitors as anticancer drugs[J]. Curr Drug Targets, 2010, 11(3), 291-302.
[10]
Węsierska-Gądek J,Maurer M. Promotion of apoptosis in cancer cells by selective purine derived pharmacological CDK inhibitors:one outcome, many mechanisms[J]. Curr Pharm Des, 2011, 17(3): 256-71.
[11]
Yu Z,Gao YQ,Feng H, et al.Cell cycle-related kinase mediates viral-host signalling to promote hepatitis B virus-associated hepato carcinogenesis[J]. Gut, 2014, 63(11): 1793-804.
[1] 孔莹莹, 谢璐涛, 卢晓驰, 徐杰丰, 周光居, 张茂. 丁酸钠对猪心脏骤停复苏后心脑损伤的保护作用及机制研究[J]. 中华危重症医学杂志(电子版), 2023, 16(05): 355-362.
[2] 张晓燕, 肖东琼, 高沪, 陈琳, 唐发娟, 李熙鸿. 转录因子12过表达对脓毒症相关性脑病大鼠大脑皮质的保护作用及其机制[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 540-549.
[3] 姚宏伟, 魏鹏宇, 高加勒, 张忠涛. 不断提高腹腔镜右半结肠癌D3根治术的规范化[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 1-4.
[4] 杜晓辉, 崔建新. 腹腔镜右半结肠癌D3根治术淋巴结清扫范围与策略[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 5-8.
[5] 周岩冰, 刘晓东. 腹腔镜右半结肠癌D3根治术消化道吻合重建方式的选择[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 9-13.
[6] 燕速, 霍博文, 徐惠宁. 4K荧光腹腔镜扩大右半结肠CME+D3根治术及No.206、No.204组淋巴结清扫术[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 14-14.
[7] 徐伯麒, 陶亮, 章帆, 毛忠琦. 结肠癌患者淋巴结转移预测模型的建立[J]. 中华普外科手术学杂志(电子版), 2023, 17(04): 393-397.
[8] 刘硕儒, 王功炜, 张斌, 李书豪, 胡成. 新型溶瘤病毒M1激活内质网应激致前列腺癌细胞凋亡的机制[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 388-393.
[9] 蓝冰, 王怀明, 王辉, 马波. 局部晚期结肠癌膀胱浸润的研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 505-511.
[10] 侯文运, 刘恒昌, 窦利州, 陈海鹏, 郑朝旭, 王贵齐, 王锡山. 腹部无辅助切口内镜引导下取标本的腹腔镜辅助右半结肠癌根治术(保留回盲部)(附视频)[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 436-440.
[11] 唐新, 刁德昌, 廖伟林, 林佳鑫, 汪佳豪, 李文娟, 谢嘉欣, 敖琳, 李洪明, 易小江, 卢新泉, 冯晓创. 保留神经的鞘外游离技术在腹腔镜右半结肠癌D3根治术中的近远期疗效分析:基于倾向性评分匹配的回顾性队列研究[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 372-380.
[12] 陈润芝, 杨东梅, 徐慧婷. 信迪利单抗联合索凡替尼后线治疗MSS型BRAF突变的转移性结肠癌:个案报道并文献复习[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 431-435.
[13] 常远, 白杨, 王文秀, 孙振强, 周全博, 崔雯铭, 王玉行, 袁维堂, 胡军红. 电子结肠镜辅助经结肠取标本手术在结肠肿瘤中的临床应用分析[J]. 中华结直肠疾病电子杂志, 2023, 12(03): 196-199.
[14] 于迪, 于海波, 吴焕成, 李玉明, 苏彬, 陈馨. 发状分裂相关增强子1差异表达对胆固醇刺激下血管内皮细胞的影响[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(05): 264-270.
[15] 邱甜, 杨苗娟, 胡波, 郭毅, 何奕涛. 亚低温治疗脑梗死机制的研究进展[J]. 中华脑血管病杂志(电子版), 2023, 17(05): 518-521.
阅读次数
全文


摘要